Contact

All Stories

  1. Patterns and Duration of Antidepressant Use in Australian Women: Findings From the Australian Longitudinal Study on Women’s Health

    Article • Asia Pacific Journal of Public Health, March 2025, SAGE Publications

    Dr Sam Hollingworth

  2. People benefit-risk assessment of vaccines: development and validation of methodological filters for use in PubMed and Embase

    Article • June 2024, University of Queensland Library

    Christine Dalais, Dr Sam Hollingworth

  3. Trends in antihypertensive use among privately insured hypertensive clients in Ghana

    Article • Journal of Human Hypertension, January 2024, Springer Science + Business Media

    Mrs AFIA AFAm Marfo, Dr Sam Hollingworth

  4. Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources

    Article • Cost Effectiveness and Resource Allocation, August 2023, Springer Science + Business Media

    Dr Sam Hollingworth

  5. Antimicrobial stewardship: Prescribing across the primary care health professions

    Article • Pharmacology Research & Perspectives, June 2023, Wiley

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  6. Nurse practitioner and midwife antibiotic prescribing in Australia

    Article • European Journal of Midwifery, May 2023, E.U. European Publishing

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  7. Publicly subsidised smoking cessation medicines in times of COVID‐19 in Australia: An interrupted time series analysis

    Article • Drug and Alcohol Review, September 2022, Wiley

    Dr Sam Hollingworth

  8. How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review

    Article • Pathogens and Global Health, August 2022, Taylor & Francis

    Dr Sam Hollingworth

  9. Antihypertensive medicine use differs between Ghana and Nigeria

    Article • BMC Cardiovascular Disorders, August 2022, Springer Science + Business Media

    Dr Sam Hollingworth

  10. Parity in female authorship in Australian pharmacoepidemiology research leveraging medicine dispensing data: How well are we doing?

    Article • Pharmacoepidemiology and Drug Safety, May 2022, Wiley

    Dr Sam Hollingworth

  11. Patient concerns regarding antidepressant drug–drug interactions: a retrospective analysis using data from a medicines call centre

    Article • Journal of Primary Health Care, April 2022, CSIRO Publishing

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  12. Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies

    Article • Journal of the Medical Library Association JMLA, November 2021, University Library System, University of Pittsburgh

    Christine Dalais, Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  13. Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholders

    Article • F1000Research, November 2021, Faculty of 1000, Ltd.

    Dr Sam Hollingworth

  14. Long term impact of the WHI studies on information-seeking and decision-making in menopause symptoms management: a longitudinal analysis of questions to a medicines call centre

    Article • BMC Women s Health, October 2021, Springer Science + Business Media

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  15. Harnessing medicines data at low cost to deliver better and safer care

    Article • Pharmacoepidemiology and Drug Safety, September 2021, Wiley

    Dr Sam Hollingworth

  16. Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis

    Article • Cost Effectiveness and Resource Allocation, July 2021, Springer Science + Business Media

    Dr Sam Hollingworth

  17. Clozapine use and prevalence in Australia 2016–2020

    Article • Australian & New Zealand Journal of Psychiatry, July 2021, SAGE Publications

    Dr Sam Hollingworth

  18. Opioid medication prescribing in Queensland, 1997‒2018: a population study

    Article • The Medical Journal of Australia, June 2021, Wiley

    Dr Sam Hollingworth

  19. Disease modifying therapies for relapsing-remitting multiple sclerosis: Use and costs in Australia (1996-2019)

    Article • Multiple Sclerosis and Related Disorders, May 2021, Elsevier

    Dr Sam Hollingworth

  20. Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real‐world study

    Article • Pharmacoepidemiology and Drug Safety, April 2021, Wiley

    Dr Sam Hollingworth

  21. Measuring Medicine Use: Applying ATC/DDD Methodology to Real-World Data

    Article • Pharmacy, March 2021, MDPI AG

    Dr Sam Hollingworth

  22. Trends in Australian dental prescribing of antibiotics: 2005–2016

    Article • Australian Dental Journal, March 2021, Wiley

    Associate Professor Treasure Madeleine McGuire, Dr Pauline J Ford, Dr Sam Hollingworth

  23. Research governance authorisation: the next frontier

    Article • Australian Health Review, January 2021, CSIRO Publishing

    Dr Sam Hollingworth

  24. Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: costing analysis*

    Article • Australian Health Review, December 2020, CSIRO Publishing

    Dr Sam Hollingworth

  25. Antidepressant use in Australia and Sweden—A cross‐country comparison

    Article • Pharmacoepidemiology and Drug Safety, November 2020, Wiley

    Dr Sam Hollingworth

  26. Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years

    Article • International Journal of Clinical Pharmacy, September 2020, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  27. Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin

    Article • Australian Health Review, September 2020, CSIRO Publishing

    Dr Sam Hollingworth

  28. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria

    Article • Globalization and Health, July 2020, Springer Science + Business Media

    Dr Sam Hollingworth

  29. Withdrawal and Misuse Concerns of Consumers regarding Opioid Analgesic and Anxiolytic, Hypnotic and Sedative Medicines

    Article • Substance Use & Misuse, July 2020, Taylor & Francis

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  30. Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia

    Article • International Journal of Clinical Pharmacy, June 2020, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  31. Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center

    Article • BMC Rheumatology, June 2020, Springer Science + Business Media

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  32. What do we know about health technology assessment (HTA) in Africa?

    Article • F1000Research, May 2020, Faculty of 1000, Ltd.

    Dr Sam Hollingworth

  33. Bortezomib use and outcomes for the treatment of multiple myeloma

    Article • Internal Medicine Journal, May 2020, Wiley

    Dr Sam Hollingworth

  34. What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana

    Article • Health Research Policy and Systems, April 2020, Springer Science + Business Media

    Dr Sam Hollingworth

  35. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?

    Article • International Journal of Infectious Diseases, December 2019, Elsevier

    Dr Sam Hollingworth, Associate Professor Treasure Madeleine McGuire

  36. Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process

    Article • International Journal of Technology Assessment in Health Care, November 2019, Cambridge University Press

    Dr Sam Hollingworth

  37. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

    Article • Expert Opinion on Drug Safety, October 2019, Taylor & Francis

    Professor Steve R Kisely, Wade Marteene, Dr Sam Hollingworth

  38. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

    Article • Research in Social and Administrative Pharmacy, August 2019, Elsevier

    Dr Sam Hollingworth

  39. Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

    Article • Climacteric, April 2019, Taylor & Francis

    Associate Professor Treasure Madeleine McGuire, Rifani Natari, Dr Sam Hollingworth

  40. Does consumer medicines interest reflect medicines use? An observational study comparing medicines call center queries with medicines use

    Article • Research in Social and Administrative Pharmacy, April 2019, Elsevier

    Dr Sam Hollingworth, Associate Professor Treasure Madeleine McGuire

  41. Medicine use during acute and chronic postinjury periods in whiplash-injured individuals

    Article • Pain, April 2019, Wolters Kluwer Health

    Dr Sam Hollingworth

  42. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life

    Article • Diabetes Care, December 2018, American Diabetes Association

    Dr Sam Hollingworth, Nicholas Graves

  43. Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country

    Article • Journal of Pharmaceutical Health Services Research, August 2018, Wiley

    Dr Sam Hollingworth

  44. Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

    Article • Drug Safety, May 2018, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  45. Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib

    Article • Anti-Cancer Drugs, May 2018, Wolters Kluwer Health

    Dr Sam Hollingworth

  46. Correction to: Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

    Article • Psychopharmacology, April 2018, Springer Science + Business Media

    Dr Sam Hollingworth

  47. Use of complementary and alternative medicines in people with depression and central obesity: Findings from a Tai Chi and Qigong study

    Article • Journal of Traditional Chinese Medical Sciences, April 2018, Elsevier

    Dr Sam Hollingworth

  48. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

    Article • Psychopharmacology, March 2018, Springer Science + Business Media

    Dr Sam Hollingworth

  49. Cost saving with a GP-led integrated health service delivery model for complex chronic disease: an optimal Beacon practice

    Article • International Journal of Integrated Care, March 2018, Ubiquity Press, Ltd.

    Dr Sam Hollingworth

  50. Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

    Article • CNS Drugs, March 2018, Springer Science + Business Media

    Dr Adeleke David Adewumi, Dr Sam Hollingworth

  51. More needs to be spent on hepatitis C treatment, not less

    Article • Internal Medicine Journal, March 2018, Wiley

    Dr Sam Hollingworth

  52. Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australia

    Article • Digestive and Liver Disease, March 2018, Elsevier

    Dr Sam Hollingworth

  53. Treatment of clozapine-associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

    Article • Diabetes Obesity and Metabolism, December 2017, Wiley

    Dr Sam Hollingworth

  54. Impact of a general practitioner-led integrated model of care on the cost of potentially preventable diabetes-related hospitalisations

    Article • Primary Care Diabetes, August 2017, Elsevier

    Dr Sam Hollingworth

  55. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition

    Article • Menopause The Journal of The North American Menopause Society, July 2017, Wolters Kluwer Health

    Associate Professor Treasure Madeleine McGuire, Rifani Natari, Dr Sam Hollingworth

  56. Opioid analgesic use in Australia and The Netherlands: a cross-country comparison

    Article • International Journal of Clinical Pharmacy, June 2017, Springer Science + Business Media

    Dr Sam Hollingworth

  57. Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting

    Article • International Journal of Clinical Pharmacy, June 2017, Springer Science + Business Media

    Dr Sam Hollingworth

  58. International trends in clozapine use: a study in 17 countries

    Article • Acta Psychiatrica Scandinavica, May 2017, Wiley

    Dr Prasad S Nishtala, Dr Jorge E Machado-Alba, Dr Sam Hollingworth

  59. Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012

    Article • Community Dentistry And Oral Epidemiology, March 2017, Wiley

    Dr Pauline J Ford, Dr Sam Hollingworth

  60. The impact of clozapine on hospital use: a systematic review and meta-analysis

    Article • Acta Psychiatrica Scandinavica, February 2017, Wiley

    Dr Sam Hollingworth

  61. Triptan use in Australia 1997-2015: A pharmacoepidemiological study

    Article • Acta Neurologica Scandinavica, January 2017, Wiley

    Dr Sam Hollingworth

  62. Forecasting the quantity and cost of medicines to treat non-communicable diseases in low- and middle-income countries: Applying knowledge on medicine use from developed countries

    Article • Research in Social and Administrative Pharmacy, January 2017, Elsevier

    Dr Sam Hollingworth

  63. Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare Providers

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2017, JCDR Research and Publications

    Dr Sam Hollingworth

  64. Under-reporting of socio-economic status in randomized control trials of biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis

    Article • Rheumatology, December 2016, Oxford University Press (OUP)

    Dr Sam Hollingworth

  65. Prescribing patterns of dental practitioners in Australia from 2001 to 2012. Antimicrobials

    Article • Australian Dental Journal, December 2016, Wiley

    Dr Pauline J Ford, Dr Sam Hollingworth

  66. Ezetimibe: Use, costs, and adverse events in Australia

    Article • Cardiovascular Therapeutics, December 2016, Wiley

    Dr Sam Hollingworth

  67. Off-label use of tumour necrosis factor-alpha inhibitors and anakinra at an Australian tertiary hospital

    Article • Internal Medicine Journal, December 2016, Wiley

    Dr Sam Hollingworth

  68. Case conference primary-secondary care planning at end of life can reduce the cost of hospitalisations

    Article • BMC Palliative Care, September 2016, Springer Science + Business Media

    Dr Sam Hollingworth

  69. Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy

    Article • Journal of Pharmacy Practice and Research, July 2016, Wiley

    Dr Centaine L Snoswell, Dr Sam Hollingworth

  70. Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland

    Article • Asia-Pacific Journal of Clinical Oncology, July 2016, Wiley

    Dr Sam Hollingworth

  71. Associations of Guideline Recommended Medications for Acute Coronary Syndromes With Fall-Related Hospitalizations and Cardiovascular Events in Older Women With Ischemic Heart Disease

    Article • The Journals of Gerontology Series A, July 2016, Oxford University Press (OUP)

    Dr Sam Hollingworth

  72. Pharmacy workforce to prevent and manage non-communicable diseases in developing nations: The case of Nepal

    Article • Research in Social and Administrative Pharmacy, July 2016, Elsevier

    Dr Sam Hollingworth

  73. A Review of Medication Use as an Indicator of Human Health Impact in Environmentally Stressed Areas

    Article • Annals of Global Health, June 2016, Ubiquity Press, Ltd.

    Dr Sam Hollingworth

  74. ‘Repeat’ prescriptions and antibiotic resistance: findings from Australian community pharmacy

    Article • International Journal of Pharmacy Practice, June 2016, Wiley

    Dr Sam Hollingworth

  75. Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study

    Article • British Journal of General Practice, May 2016, Royal College of General Practitioners

    Dr Sam Hollingworth

  76. Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

    Article • Journal of Psychopharmacology, January 2016, SAGE Publications

    Dr Sam Hollingworth

  77. Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy

    Article • International Journal of Clinical Pharmacy, September 2015, Springer Science + Business Media

    Dr Sam Hollingworth

  78. Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia

    Article • Drugs - Real World Outcomes, July 2015, Springer Science + Business Media

    Associate Professor Treasure Madeleine McGuire, Dr Sam Hollingworth

  79. Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal

    Article • Perspectives in Public Health, July 2015, SAGE Publications

    Dr Sam Hollingworth

  80. Clozapine in the community: Improved access or risky free-for-all?

    Article • Australian & New Zealand Journal of Psychiatry, June 2015, SAGE Publications

    Dr Sam Hollingworth

  81. Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

    Article • Pharmacopsychiatry, June 2015, Thieme Publishing Group

    Dr Sam Hollingworth

  82. Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

    Article • BJPsych Open, June 2015, Royal College of Psychiatrists

    Dr Sam Hollingworth

  83. Opioid analgesic prescribing in Australia: a focus on gender and age

    Article • Pharmacoepidemiology and Drug Safety, April 2015, Wiley

    Wayne Hall, Dr Sam Hollingworth

  84. Multiple sclerosis disease modifying medicine utilisation in Australia

    Article • Journal of Clinical Neuroscience, December 2014, Elsevier

    Dr Sam Hollingworth

  85. Clozapine-induced myocarditis: Separating the wheat from the chaff

    Article • Australian & New Zealand Journal of Psychiatry, October 2014, SAGE Publications

    Dr Sam Hollingworth

  86. Effects of decentralisation and health system reform on health workforce and quality-of-care in Indonesia, 1993-2007

    Article • The International Journal of Health Planning and Management, May 2014, Wiley

    Dr Sam Hollingworth

  87. Quality of physical resources of health facilities in Indonesia: a panel study 1993-2007

    Article • International Journal for Quality in Health Care, August 2013, Oxford University Press (OUP)

    Dr Sam Hollingworth

  88. National trends in the community prescribing of second-generation antipsychotic medications in Australian children and youth: the incomplete story

    Article • Australasian Psychiatry, July 2013, SAGE Publications

    Dr Sam Hollingworth

  89. Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia

    Article • Australian and New Zealand Journal of Public Health, April 2013, Wiley

    Dr Sam Hollingworth

  90. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis

    Article • Multiple Sclerosis Journal, March 2013, SAGE Publications

    Dr Sam Hollingworth

  91. A new model of integrated primary-secondary care for complex diabetes in the community: study protocol for a randomised controlled trial

    Article • Trials, January 2013, Springer Science + Business Media

    Dr Sam Hollingworth

  92. The prescribing of antiepileptic drugs for pregnant Australian women

    Article • Australian and New Zealand Journal of Obstetrics and Gynaecology, September 2011, Wiley

    Dr Sam Hollingworth

  93. Psychiatric Drug Prescribing in Elderly Australians: Time for Action

    Article • Australian & New Zealand Journal of Psychiatry, September 2011, SAGE Publications

    Dr Sam Hollingworth

  94. Australian National Trends in Stimulant Dispensing: 2002–2009

    Article • Australian & New Zealand Journal of Psychiatry, April 2011, SAGE Publications

    Dr Sam Hollingworth

  95. Utilization of anti-Parkinson drugs in Australia: 1995-2009

    Article • Pharmacoepidemiology and Drug Safety, February 2011, Wiley

    Dr Sam Hollingworth

  96. Prescribing trends in cognition enhancing drugs in Australia

    Article • International Psychogeriatrics, July 2010, Cambridge University Press

    Dr Sam Hollingworth

  97. Marked increase in proton pump inhibitors use in Australia

    Article • Pharmacoepidemiology and Drug Safety, July 2010, Wiley

    Dr Sam Hollingworth

  98. Patterns of Antipsychotic Medication Use in Australia 2002–2007

    Article • Australian & New Zealand Journal of Psychiatry, April 2010, SAGE Publications

    Dr Sam Hollingworth

  99. Secondary Prevention of Osteoporosis in Australia

    Article • Drugs & Aging, March 2010, Springer Science + Business Media

    Dr Sam Hollingworth

  100. Changing patterns of antiepileptic drug use in pregnant Australian women

    Article • Acta Neurologica Scandinavica, February 2010, Wiley

    Dr Sam Hollingworth

  101. Anxiolytic, hypnotic and sedative medication use in Australia

    Article • Pharmacoepidemiology and Drug Safety, January 2010, Wiley

    Dr Sam Hollingworth

  102. Antiepileptic drugs in Australia: 2002–2007

    Article • Pharmacoepidemiology and Drug Safety, January 2010, Wiley

    Dr Sam Hollingworth

  103. In Australia are people born in other countries at higher risk of road trauma than locally born people?

    Article • Accident Analysis & Prevention, May 2004, Elsevier

    Dr Sam Hollingworth

  104. Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep

    Article • Endocrinology, June 1996, Endocrine Society

    Dr Sam Hollingworth

  105. Continuous intrafetal infusion of prostaglandin E2 prematurely activates the hypothalamo-pituitary-adrenal axis and induces parturition in sheep.

    Article • Endocrinology, June 1996, Endocrine Society

    Dr Sam Hollingworth

  106. Rebound increase in fetal breathing movements after 24-h prostaglandin E2 infusion in fetal sheep

    Article • Journal of Applied Physiology, January 1996, American Physiological Society

    Dr Sam Hollingworth

  107. Prostaglandin E2 administered to fetal sheep increases the plasma concentration of adrenocorticotropin (ACTH) and the proportion of ACTH in low molecular weight forms.

    Article • Endocrinology, March 1995, Endocrine Society

    Dr Sam Hollingworth

  108. Prostaglandin E2 administered to fetal sheep increases the plasma concentration of adrenocorticotropin (ACTH) and the proportion of ACTH in low molecular weight forms

    Article • Endocrinology, March 1995, Endocrine Society

    Dr Sam Hollingworth

  109. Chronic administration of low doses of adrenocorticotropin to hypophysectomized fetal sheep leads to normal term labor

    Article • Endocrinology, March 1994, Endocrine Society

    Dr Sam Hollingworth

  110. Effect of Late Hypothalamo-Pituitary Disconnection on the Development of the HPA Axis in the Ovine Fetus and the Initiation of Parturition

    Article • Journal of Neuroendocrinology, February 1994, Wiley

    Dr Sam Hollingworth

  111. The metabolism and excretion of oestradiol-3β-d-glucuronide in rats

    Article • Comparative Biochemistry and Physiology Part B Comparative Biochemistry, January 1988, Elsevier

    Dr Sam Hollingworth